AstraZeneca plc (ADR) (NYSE:AZN)

CAPS Rating: 4 out of 5

The Company discovers, develops, manufactures and markets prescription pharmaceuticals for important areas of healthcare: cancer, cardiovascular, gastrointestinal, infection, neuroscience, and respiratory and inflammation.

Recs

0
Player Avatar banikp (< 20) Submitted: 7/17/2012 5:23:56 AM : Outperform Start Price: $45.15 AZN Score: -1.00

This company is a star in an industry that is filled with great companies. Based on the valuation metrics, I would pick this company over any of its' competitors right now.

Featured Broker Partners


Advertisement